Age ≥75 | |
---|---|
N = 20 | |
Gender n (%) | |
Male | 12 (60.0) |
Female | 8 (40.0) |
Age mean (range, SD) | 76.7 (75–85) |
Year of operation n (%) | |
1996–2002 | 0 |
2003–2007 | 6 (30.0) |
2008–2013 | 14 (70.0) |
Diagnosis n (%) | |
CRC (n = 184) | 5 (25.0) |
PMP (n = 157) | 6 (30.0) |
Mesothelioma (n = 53) | 2 (10.0) |
Appendiceal cancer (n = 137) | 6 (30.0) |
Others (n = 80) | 1 (5.0) |
HIPEC n (%) | 9 (45.0) |
EPIC n (%) | 5 (25.0) |
PCI mean (SD) | 22.8 (13.0) |
CC n (%) | |
0 | 11 (55.0) |
1 | 5 (25.0) |
2 | 3 (15.0) |
3 | 0 (0) |
Transfusion mean (SD) | 5.2 (6.2) |
Total hospital stay (days) median (range) | 20.0 (9–157) |
ICU stay (days) median (range) | 2.0 (1–101) |
HDU stay (days) median (range) | 1.0 (0–20) |
Hospital death n (%) | 1 (5) |
Complication grade n (%) | |
0 | 5 (25.0) |
I | 1 (5.0) |
II | 4 (20.0) |
III | 6 (30.0) |
IV | 4 (20.0) |
Tumour-related OS median (months) (95 %) | 35.0 (17.3–52.7) |
5-year OS (%) | 18.6 |